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Abstract 
Background: The pathological hallmarks of Parkinson’s disease are intracellular inclusions composed mainly of mis-
folded α-synuclein (αSYN). Under physiological conditions αSYN is mostly localized in synapses. In addition, a portion 
of αSYN is secreted to the extracellular space, where it may be sequestered by neighboring cells and could induce 
inflammatory responses. The mechanisms of αSYN internalization and signal transduction are not unequivocally 
clarified. In this work we investigated in primary mouse astrocytes the involvement of toll-like receptor 4 (TLR4) in the 
induction of inflammatory responses upon exposure to purified human αSYN produced in bacteria.
Results: The mRNA induction of pro-inflammatory cytokines, inducible nitric oxide synthase and cyclooxygenase-2 
was significantly reduced in TLR4 knockout astrocytes. The αSYN-mediated activation of c-Jun N-terminal kinases 
and p38 mitogen-activated protein kinase tended to be diminished, and nuclear translocation of the p65 subunit of 
nuclear factor κB was abolished in TLR4 knockout astrocytes. In contrast, the uptake of exogenous αSYN was unaf-
fected by TLR4 knockout.
Conclusions: Extracellular αSYN can activate pro-inflammatory TLR4 pathways in astrocytes, whereas αSYN uptake is 
independent of TLR4.
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Background
Inflammation in the central nervous system is character-
ized by increased activation of microglia and astrocytes, 
elevated production of cytokines and other pro-inflam-
matory mediators including nitric oxide (NO) and 
prostaglandins, enhanced blood–brain-barrier perme-
ability and hence increased leukocyte invasion. Neu-
roinflammation is an acutely protective mechanism, 
however, long-lasting and persistent formation and 
accumulation of pro-inflammatory mediators can initi-
ate neuronal damage, neuronal circuit impairments and 
neurodegeneration. Correspondingly prolonged activa-
tion of neuroinflammation is thought to play a destruc-
tive role in many neurodegenerative diseases [1].
Parkinson’s disease (PD) is the most common neuro-
degenerative movement disorder, which affects approxi-
mately 1  % of the population over 65  years of age. 
Postmortem studies have shown an increase in neuro-
inflammatory signals in the brains of PD patients. Acti-
vated microglia and astrogliosis have been found in the 
affected substantia nigra of PD patients [2, 3]. Moreover, 
a higher density of CD8+ and CD4+ T-cells was shown 
in PD brains than in healthy control brains [4]. Corre-
spondingly, the neuroinflammatory pathology found in 
brains of PD patients has been reproduced in several PD 
animal models [5].
Most of the glial cells in the brain are astrocytes, which 
are present in all regions of the brain and are localized in 
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strategic positions in close proximity to neurons. Astro-
cytes are important contributors to the inflammatory 
responses during brain injury and infection. Similar to 
microglia, astrocytes can express and secrete a variety of 
molecules that modulate inflammation, for example toll-
like receptors (TLRs), proinflammatory cytokines and 
NO. TLRs are receptors that are expressed in cells of the 
innate immune system. They recognize pathogen-associ-
ated molecular patterns and certain endogenous molecu-
lar patterns. The induction of inflammatory responses by 
the bacterial endotoxin lipopolysaccharide (LPS) is medi-
ated by TLR4 [6]. Interestingly, TLR4 has been shown to 
be upregulated in microglia in synucleinopathy brains 
[7].
The pathological hallmarks of PD are intraneuronal 
protein inclusions called Lewy bodies or Lewy neurites. 
These inclusions mainly consist of the protein α-synuclein 
(αSYN) [8]. In addition, although astrocytes express only 
very low levels of αSYN themselves [9], αSYN-containing 
inclusions have been found in astrocytes in postmortem 
brains from patients with Lewy body diseases [10–12]. 
Moreover, point mutations and genomic multiplications 
of the gene encoding αSYN (SNCA) are linked to autoso-
mal-dominant PD [13–15].
αSYN contains 140 amino acids and can associate with 
lipids [16–19]. The non-amyloid component domain 
(amino acids 65–95) of αSYN is essential for its patho-
genic oligomerization and fibril formation [20]. αSYN is 
highly abundant in the brain, but is also present in other 
tissues, for example in red blood cells [21]. It is mainly 
localized in pre-synaptic terminals [19], and a small por-
tion of the protein is also secreted to the extracellular 
space [22]. Cell stress like proteasomal dysfunction or 
oxidative stress may increase the secretion of αSYN [23, 
24]. Extracellularly applied αSYN is able to induce inflam-
matory responses in neurons and glial cells [25]. Primary 
astrocytes treated with media from αSYN overexpressing 
SH-SY5Y neuroblastoma cells show increased expres-
sion of cytokines, among others the interleukins IL-6 and 
IL-1β, as well as cyclooxygenase-2 (COX-2) [26]. How-
ever, the molecular mechanisms by which αSYN induces 
neuroinflammatory responses are not entirely resolved. 
TLR4 was reported to mediate αSYN induction of tumor 
necrosis factor-α (TNF-α) and IL-6 in both microglia and 
astroglia [27]. On the other hand, TLR2 was reported to 
mediate microglial activation (proliferation and cytokine 
production) in response to cell-secreted αSYN [28], and 
β1-integrin signaling mediated the morphological and 
motility responses [29]. Moreover, pre-conditioning 
microglia with αSYN alters TLR responses [30].
The aim of this study was to investigate the role of 
TLR4 in the activation of inflammatory responses in 
astrocytes in the presence of extracellular αSYN. Primary 
astrocyte-rich cultures from TLR4 knockout mice and 
littermate controls were treated with purified recombi-
nant human αSYN produced in bacteria. Moreover the 
internalization of extracellular αSYN into primary astro-
cytes was investigated. Our results indicate that αSYN 
is able to activate TLR4 signal transduction and thereby 
induces the expression of pro-inflammatory cytokines, 
inducible NO synthase (Nos2) and Cox-2, to mediate 
nuclear translocation of nuclear factor κB (NF-κB) and to 
activate c-Jun N-terminal kinase (JNK) and p38 mitogen-
activated protein kinase (MAPK) modules. In contrast, 
the uptake of extracellular αSYN into astrocytes appears 
to be mediated by TLR4-independent pathway(s).
Results
Treatment with recombinant αSYN induces 
TLR4‑dependent gene expression in primary astrocyte 
cultures
To investigate if TLR4 plays a role in inflammatory reac-
tions to exogenous αSYN, primary littermate Tlr4+/+ and 
Tlr4−/− astrocytes were treated with recombinant αSYN, 
and LPS as a positive control. The expression of Nos2, 
Il-6, Il1b, Cox-2, Tnfa and Ngf mRNA was investigated 
by semi-quantitative PCR. LPS dramatically induced 
the expression of Nos2, Il-6, Il1b, and Cox-2 in Tlr4+/+ 
astrocytes (Fig.  1). Tnfa expression was also enhanced 
by LPS treatment while Ngf expression was less consist-
ently altered. Though significantly reduced (Fig.  1b), 
some induction by LPS could be detected also in Tlr4−/− 
astrocytes. This might reflect the ability of LPS to acti-
vate additional receptors, such as TLR2 [31]. Treatment 
with 0.7 µM αSYN induced the expression of Nos2, Il-6, 
Il1b, and Cox-2 in Tlr4+/+ but no significant induction 
was detected in Tlr4−/− astrocytes (Fig. 1b). Tnfa expres-
sion was elevated by αSYN in Tlr4+/+ astrocytes, but 
remained at basal levels in Tlr4−/− astrocytes.
Time course experiments confirmed the inductions 
within few hours of Nos2 and Cox-2 as well as Il-6 and 
Il1b, which were abolished in Tlr4−/− astrocytes (Fig. 2). 
Tnfa was similarly induced by αSYN while again only 
basal expression remained in Tlr4−/− astrocytes. Wash-
out of agonists showed the reversible nature of astrocyte 
stimulations (Fig. 2). We also measured NO release from 
stimulated astrocytes (Additional file 1: Figure S1). Simi-
lar to LPS, αSYN treatment clearly induced NO release, 
although overall the variance of this assay was high. Nev-
ertheless, administration of viper peptide that inhibits 
TLR4 largely abolished NO release, in contrast to the 
control peptide (Additional file 1: Figure S1). In conclu-
sion, the mRNA induction of pro-inflammatory media-
tors by extracellularly applied αSYN involves TLR4.
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Decreased p38 and JNK phosphorylation in Tlr4−/− 
astrocytes after αSYN treatment
Since mRNA inductions of inflammatory mediators by 
extracellular αSYN appeared to depend on the presence 
of TLR4 we wondered if other pathways that are acti-
vated by TLR4 were also affected. Therefore we treated 
primary astrocytes from littermate Tlr4+/+ and Tlr4−/− 
mice with LPS as positive control or recombinant human 
αSYN for 1 h. The cells were recovered in growth media 
for 0–24 h (Additional file 2: Figure S2A) and immuno-
blotting was performed using antibodies against phos-
phorylated (activated) p38 MAPK and JNK. In Tlr4+/+ 
cells treatment with αSYN led to phosphorylation of p38 
MAPK and JNK whereas in Tlr4−/− less induction of the 
phosphorylation was seen. In another experiment the 
astrocytes were continuously treated with LPS and αSYN 
for 0–24  h (Additional file  2: Figure S2B). Also in this 
experiment we could detect increased phosphorylation 
of p38 MAPK and JNK after 2–6 h in Tlr4+/+ astrocytes. 
Again the induction of p38 MAPK and JNK phosphoryla-
tion tended to be reduced in Tlr4−/− astrocytes. In con-
clusion, treatment of astrocyte-rich primary cell cultures 
with recombinant αSYN induced phosphorylation of p38 
MAPK and JNK, involving TLR4.
Extracellularly applied αSYN does not cause to nuclear 
translocation of NF‑κB in Tlr4−/− astrocytes
Activation of TLR4 leads to phosphorylation and deg-
radation of IκB and thus allows the transcription factor 
complex NF-κB to translocate to the nucleus. Primary 
Tlr4+/+ and Tlr4−/− astrocytes were treated with dif-
ferent concentrations of the positive control LPS or 
recombinant human αSYN for 6 h. The cells were immu-
nostained for p65, a component of the class II NF-κB 
protein complex, and p65 positive nuclei were quanti-
fied. As expected, LPS treated cells showed an increased 
number of p65 positive nuclei in both Tlr4+/+ and 
Tlr4−/− cells, however to a lesser extent in the knock 
out astrocytes (Fig.  3). The recombinant αSYN induced 
Fig. 1 mRNA induction of pro-inflammatory mediators by extra-
cellular αSYN is reduced in Tlr4−/− primary astrocytes. a Primary 
astrocyte-rich cultures from littermate Tlr4+/+ and Tlr4−/− mice were 
treated for 72 h with indicated concentrations of LPS (as positive 
control) and αSYN, or left untreated (Ø). Total RNA was isolated from 
the cells and semi-quantitative PCR was performed with primers 
specific for the indicated gene products. Expression of β-actin mRNA 
(Actb) was measured as loading control. Images representative for 5–6 
independent cultures are shown. b Ethidium bromide stained RT-PCR 
band signals were quantified with ImageJ software and normalized 
to Actb. Error bars indicate standard deviation, #p < 0.05 compared 
to untreated samples (ANOVA Fisher’s PLSD), *p < 0.05 compared to 
Tlr4−/− (Student’s t test)
◂
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Fig. 2 Time course and recovery of pro-inflammatory mediator expression. a Primary astrocyte-rich cultures from littermate Tlr4+/+ and Tlr4−/− 
mice were treated for 1 h with 1.0 µg/ml LPS (as positive control) or 0.7 µM αSYN, after which the cells were allowed to recover in growth media for 
1, 4 or 23 h. Parallel cultures were continuously treated with 1.0 µg/ml LPS or 0.7 µM αSYN for 2, 5 or 24 h. Control cells were left untreated (-). Total 
RNA was isolated and semi-quantitative PCR was performed as in Fig. 1a. Images representative for 4–5 independent cultures are shown. b RT-PCR 
band quantifications were done as described for Fig. 1b. Error bars indicate standard deviation, #p < 0.05 compared to untreated samples (ANOVA 
Fisher’s PLSD), *p < 0.05 compared to Tlr4−/− (Student’s t test)
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NF-κB translocation in Tlr4+/+ cells in a concentration 
dependent manner, whereas in Tlr4−/− astrocytes very 
few p65 positive nuclei were detected. Thus indicating 
that extracellular αSYN can induce the nuclear transloca-
tion of NF-κB in a TLR4-dependent manner.
Primary astrocytes internalize αSYN from the medium in a 
TLR4‑independent manner
Different studies have indicated that a variety of cell 
types, for example neuronal cells, microglia and astro-
cytes, are able to internalize extracellular αSYN [26, 32]. 
The mechanism of the uptake of the monomeric form 
has been suggested to differ from the uptake of oligo-
meric and fibrillar αSYN [33]. We investigated if primary 
Tlr4+/+ and Tlr4−/− astrocytes cultures were able to 
internalize the recombinant αSYN. Indeed, after 48 h of 
continuous incubation an immunoblot signal for human 
αSYN could be detected in samples that had been treated 
with 0.07 or 0.7 µM wild-type αSYNwt, mutant αSYNA30P 
or phosphorylation-deficient αSYNS129A (Fig.  4a). No 
considerable difference in the internalization of differ-
ent αSYN variants or between the genotypes of astro-
cytes could be detected. Pathological αSYN is extensively 
phosphorylated at S129 and at this site phosphorylated 
αSYN is found in Lewy bodies [34]. To see if the internal-
ized αSYN is phosphorylated in the astrocytes we treated 
primary astrocyte cultures with recombinant αSYN for 
48  h. No signal could be detected with a phospho-S129 
αSYN specific antibody (Fig.  4b). As a positive control 
for the antibody we used brain lysate from an aged SNCA 
transgenic mouse, which harbors excessive amounts of 
S129 phosphorylated αSYN [35]. Also the αSYNS129A 
mutant was internalized (Fig. 4b), suggesting that phos-
phorylation at S129 is not a predominant factor in astro-
cytic uptake of αSYN.
Next we made a time course experiment where pri-
mary astrocyte cultures were treated continuously for 
0–48  h with recombinant human αSYN. Already after 
1  h the astrocytes had internalized detectable amounts 
of the recombinant αSYN. Interestingly, the intensity of 
the signal from internalized αSYN diminished with time 
(Fig. 4c). Thus, astrocytes seem to be able to purge extra-
cellular αSYN.
Discussion
The molecular mechanisms that trigger degeneration of 
the dopaminergic neurons in PD are still under investiga-
tion. It is currently heavily debated if αSYN can act as an 
agent that spreads neurodegeneration in PD brains and 
thus cause the progression of the disease. The role of the 
portion of αSYN that is secreted from neurons is largely 
unknown. Previous studies have shown that treatment 
Fig. 3 αSYN treatment induces TLR4 dependent nuclear translocation of NF-κB in primary astrocytes. a Primary astrocyte-rich cultures from lit-
termate Tlr4+/+ and Tlr4−/− mice were treated with indicated concentrations of LPS (as positive control) and recombinant human αSYN for 6 h or 
left untreated. The cells were fixed and immunostained using an antibody specific for p65 (green). Nuclei were counterstained with Hoechst 33342 
(blue). Images were obtained with 25× objective using Axioimager microscope equipped with ApoTome Imaging system (Carl Zeiss). Scale bars 
correspond to 20 µm. b p65/NF-κB positive versus total cells were quantified from images as shown in (a). 200–400 cells per sample were analyzed. 
Error bars show standard deviation, *p < 0.05 (Student’s t test), n is indicated in the figure
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with recombinant αSYN produced in bacteria as well as 
cell culture medium from cells that overexpress αSYN 
induces neuroinflammatory responses in microglia and 
astroglia [26, 27, 36–38]. In agreement with this we could 
see an induction of cytokines, Cox-2 and Nos2 mRNA, 
phosphorylation of p38 MAPK and JNK, and nuclear 
translocation of NF-κB in primary astrocyte rich cultures 
that had been treated with recombinant human αSYN 
purified from bacteria. Previous studies have suggested 
that TLR4 may be involved in synucleinopathies. Upregu-
lation of TLR4 has been detected in multiple system atro-
phy, both in the brains of patients with the disease and in 
brains from a transgenic mouse model of the disease [7, 
39]. Specifically, Fellner et  al. [27] recently showed that 
αSYN preparations greatly enhanced rapid secretion of 
TNF-α and C-X-C motif chemokine ligand 1, and a more 
delayed secretion of IL-6 in Tlr4+/+ astrocytes, which 
was strongly suppressed in Tlr4−/− astrocytes. Our 
present study confirms these findings at the mRNA level 
for the delayed Il-6 response, and adds Il1b to the list of 
TLR4-dependent αSYN responses. Moreover, we identify 
Nos2 and Cox-2 as potential signaling targets, and show 
the activation of MAPK and NF-κB pathways by which 
TLR4 appears to mediate pro-inflammatory responses to 
extracellular αSYN in astrocytes.
Astrocytes are in close proximity to neurons and 
neuronal synapses. These cells have been shown to be 
important scavengers of different potentially neurotoxic 
molecules that are secreted from neurons like gluta-
mate, potassium and calcium. In accordance with this, 
we could detect a fast astrocytic internalization of the 
applied extracellular αSYN followed by degradation. 
These findings are supported by a previous study where 
cell secreted αSYN was readily endocytosed by primary 
rat astrocytes [26]. This implicates that astrocytes are 
decreasing the amount of potentially proinflammatory 
Fig. 4 Extracellular αSYN is internalized by astrocytes in a TLR4 independent manner. Primary astrocytes from littermate Tlr4+/+ and Tlr4−/− mice (a) 
or Tlr4+/+ mice (b) were continuously treated for 48 h with indicated concentrations of recombinant human synucleins or LPS or left untreated (Ø). 
Cells were washed twice with PBS prior to lysis. The protein lysates were immunoblotted and probed with human-specific anti-αSYN (a, b) and also 
antibody against αSYN phosphorylated at S129 (b). GAPDH serves as control for equal protein loading throughout. Positive control in (b) is brain 
lysate from a 18 month old Thy1[A30P]hSNCA transgenic mouse, which has high amounts of phosphorylated αSYN. N is indicated in the figure (a) 
or N = 8 (b, c). c Primary wild type astrocytes were treated continuously with 0.7 µM αSYN for indicated times. Protein lysates were examined by 
immunoblotting as above
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extracellular αSYN. The exact mechanism of the uptake 
of αSYN is still being investigated. In addition, the mech-
anism of uptake of monomeric and protofibrillar αSYN 
has been suggested to differ [33]. Monomeric αSYN has 
been suggested to be able to passively diffuse through 
the plasma membrane [40]. Thus αSYN would be local-
ized in the cytosol and be directly available for protea-
somes. However, also lipid-raft mediated endocytosis 
has been suggested for the uptake of monomeric αSYN 
[41]. The reproducible TLR4-independent αSYN uptake 
route in astroglial cells observed here and by Fellner et al. 
[27] remains to be further characterized. It is presently 
unknown if other receptor(s) mediate αSYN endocytosis 
in astrocytes, or if it is a receptor-independent form of 
pinocytosis, or a non-classical internalization or mem-
brane penetration mechanism.
The formation and biological activities of oligomeric 
and fibrillar αSYN species are a vast topic in the field. 
Specifically, pre-formed fibrils are suggested to propa-
gate cell-to-cell spread of αSYN [42, 43], and specific 
types of αSYN oligomers were reported to activate TLR2 
on microglia [28]. On the other hand, “soluble” αSYN 
was a powerful stimulator of TLR4 both on microglia 
and astrocytes [27]. Cell type and receptor specifici-
ties, experimental conditions or conceptual issues could 
account for such differences. The present study did not 
focus on the nature of αSYN species involved in TLR4 
responses and uptake in astrocytes. No procedures were 
undertaken to pre-aggregate our αSYN preparations, 
but we cannot rule out the presence of some αSYN oli-
gomeric or aggregated species. Moreover, it is hard to 
predict what happens on the membrane surface, and if 
αSYN oligomers assemble near or on TLR4, or if αSYN 
oligomerizes during or after uptake. More work is nec-
essary to unravel the different roles of the various αSYN 
assemblies in the brain.
The αSYN level has been measured to be 0.01 or 
0.035  nM in the interstitial fluid of control or trans-
genic SNCA mice, respectively [44]. The inflammatory 
responses were seen when we used 0.7  µM of αSYN, 
which is a more than 20,000 times higher concentration. 
However, it is possible that the local concentration within 
synapses, which are touched by astrocytic endfeet, can be 
at least temporarily increased. It would be very interest-
ing to be capable of measuring the αSYN concentration 
within synapses and to investigate the effect of physiolog-
ically relevant extracellular αSYN concentrations.
Conclusions
Extracellular αSYN can induce inflammatory responses 
in astrocytes in a TLR4-dependent manner and this may 
worsen the stress conditions in synucleinopathy brains. 
On the other hand, astrocytes may also play a protective 
role in the disease progression by efficiently sequestering 
and degrading the proinflammatory extracellular αSYN.
Methods
Antibodies
Primary antibodies used were: rat monoclonal against 
human αSYN (15G7 [45]; provided by Dr. Elisabeth 
Kremmer, Helmholtz Center, Munich, Germany), mouse 
monoclonal anti-βSYN (Syn207; Millipore), mouse 
monoclonal against glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) (6C5; Meridian Life Sciences), 
rabbit monoclonal 3D7 against phospho-p38 MAPK 
(T180/Y182), rabbit polyclonal anti-p38 MAPK, rab-
bit polyclonal against phospho-JNK (T183/Y185), rab-
bit monoclonal 56G8 anti-JNK (all from Cell Signaling 
Technology), F-6 mouse monoclonal against NF-κB 
p65 (Santa Cruz Biotechnology) and rabbit monoclonal 
EP1536Y against αSYN phosphorylated at S129 (Abcam). 
Secondary peroxidase conjugated antibodies were pur-
chased from Jackson ImmunoResearch Laboratories and 
secondary Alexa-Fluor conjugated antibodies were pur-
chased from Invitrogen GmbH.
Synuclein expression constructs
pET30a SNCB was a kind gift from Hilal Lashuel at the 
Swiss federal institute of technology in Lausanne, Swit-
zerland. To create bacterial expression vectors SNCA wt, 
A30P and S129A were cloned from pCDNA3.1-SNCA 
[46] into NheI/HindIII site of pET21a vector (Novagen). 
The nucleic acid sequences of the constructs were con-
firmed by sequencing using BigDye Terminator v3.1 
according to the manufacturer’s instructions. Reac-
tion products were analyzed using an ABI 3100 Genetic 
Analyzer.
Preparation of recombinant αSYN
DYT medium (1.6  % (w/v) Tryptone, 1  % (w/v) Yeast 
extract, 0.5 % (w/v) NaCl) supplied with 100 µg/ml ampi-
cillin was inoculated with Escherichia Coli BL21 Rosetta2 
(Stratagene) transformed with pET21a-SNCA wt or 
mutants or pET30a-SCNB. The bacteria were grown at 
37  °C at 200  rpm to an optical density between 0.5 and 
0.8 at 590 nm. Protein expression was induced by 0.5 mM 
isopropyl-β-d-thiogalactopyranoside for 4–6  h at 37  °C 
at 200 rpm. The bacteria were centrifuged at 3500×g for 
10 min at 4 °C and the cell pellet was stored at −20 °C.
The bacterial pellet was gently diluted in a 10  mM 
phosphate buffer (pH 7.4) containing 25  mM NaCl and 
EDTA-free Cømplete protease inhibitor (Roche Diag-
nostics). The cells were homogenized in a French press 
(EmulsiFlex-C5; AVESTIN) and sonicated three times for 
30 s at 50 % input (SONOPULS HD 2070; BANDELIN). 
The solutions were incubated for 15  min at 95  °C. The 
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denatured proteins were removed by two time centrifu-
gation at 17,000×g at 4  °C for 30  min. The supernatant 
was applied on a Q-Sepharose column (50 ml, diameter 
23  mm) and eluted with a two column volumes long 
25 mM to 1000 mM NaCl gradient in 10 mM phosphate 
buffer (pH 7.4). Fractions with strong synuclein signals 
on dot blots were desalted on a Sephadex S-200 column 
(column volume 180 ml, diameter 16 mm) using a 10 mM 
phosphate buffer containing 150  mM NaCl, (pH 7.4). 
The synuclein content in the eluted fractions was moni-
tored on dot blots. Absence of contaminating proteins 
was examined in 2–5 µl samples by a sensitive variant of 
Coomassie staining (10 % (v/v) ethanol, 30 mM HCl and 
0.3  mM Coomassie Brilliant Blue G250). Fractions that 
were positive for an immunoblot synuclein signal and 
had only one visible protein band in the Coomassie gel 
were pooled, aliquoted and stored at −20 °C. The absorb-
ance at 280  nm was measured and the synuclein con-
centrations were calculated using the extinction factors 
ε(280, 0.1  %) 0.354 for αSYN and 0.417 for βSYN (cal-
culated with the ProtParam tool of ExPASy, Swiss Insti-
tute of Bioinformatics). Characterization of recombinant 
synucleins is shown in Additional file 3: Figure S3.
Endotoxin levels of the recombinant proteins were esti-
mated using PYROGENT Plus Single Tests (sensitivity 
0.06 EU/ml) following the manufacturer’s instructions 
(LONZA). Briefly, Limulus Amebocyte Lysate was dis-
solved in 250 μl of diluted protein samples (1:1, 1:10 and 
1:25), or endotoxin-free water, then incubated for 60 min 
at 37 °C.
Mouse maintenance and preparation of primary astrocytes
Mice were kept under standard conditions with free 
access to food and water in a cycle of 12  h of light and 
12 h of dark. The local animal welfare committee, Referat 
35, Regierungspräsidium Tübingen approved all experi-
ments and procedures. Number of animals used and 
their suffering was kept to a minimum.
Heterozygous Tlr4+/− mice [47] were intercrossed. 
Astrocyte-rich primary cultures were prepared as 
described previously [48]. Newborn pups were decapi-
tated, and whole brains were removed. The brain from 
each pup was handled separately. Cells were sepa-
rated in preparation buffer (137  mM NaCl, 5.4  mM 
KCl, 0.2 mM KH2PO4, 0.2 mM Na2HPO4, 1 g/l glucose, 
20  g/l sucrose, 50  µg/ml gentamycin) by mechanically 
forcing the brains through nets with a mesh width of 
first 250  µM and second 135  µm. The cells were resus-
pended in Dulbecco’s modified Eagle’s medium (Bio-
chrom) supplemented with 10 % fetal calf serum, 10 U/
ml penicillin G and 10 µg/ml streptomycin sulfate. Cells 
were cultured in 75  cm2 cell culture bottles at 37  °C in 
5  % CO2 in a humidified atmosphere. Each individual 
culture was genotyped by PCR of genomic DNA (prim-
ers Tlr4+/+rev 5′-CGTGTAAACCAGCCAGGTTTTG 
AAGGC-3′, Tlr4+/+for 5′-TGTTGCCCTTCAGTCA 
CAGAGACTCTG-3′, Tlr4−/−rev 5′-TGTTGGGTCGT 
TTGTTCGGATCCGTCG-3′). After 1  week in culture 
the flasks containing the astrocytes were shaken at 37 °C 
at 180 rpm over night. Then the cells were washed once 
with phosphate buffered saline (PBS, pH 7.4; 2.2  mM 
KH2PO4, 7.8  mM Na2HPO4, 150  mM NaCl) and fresh 
growth medium was supplied. After one additional week 
the cells were plated in appropriate cell culture dishes. In 
order to avoid stress the astrocytes were allowed to nor-
malize for 4–7  days and they were supplied with fresh 
media 1 or 2  days before use in experiments. The cells 
were incubated in growth media unless stated otherwise 
supplemented with indicated concentrations of LPS or 
recombinant synuclein for indicated times.
Semi‑quantitative PCR
Cells were lysed in RLT-RNA lysis buffer at −20 °C. RNA 
was isolated using the RNeasy Mini kit (Qiagen). cDNA 
was produced with Transcriptor High Fidelity cDNA Syn-
thesis kit (Roche Diagnostics) and anchored-oligo(dT)18 
primer. The cDNA was used as template for PCR reac-
tions with given primers (Actb: 5′-CTAAGGCCAACCG 
TGAA-3′ and 5′-CCGGAGTCCATCACAAT-3′, Il1b: 
5′-CAGGCAGGCAGTATCACTCA-3 and 5′-AGGCC 
ACAGGTATTTTGTCG-3′, Il-6: 5′-GTTCTCTGGGA 
AATCGTGGA-3 and 5′-GGAAATTGGGGTAGGAAG 
GA-3′, Cox-2: 5′-TCCTCCTGGAACATGGACTC-3′ and 
5′-CCCCAAAGATAGCATCTGGA-3′, Tnfa: 5′-AGC 
CCCCAGTCTGTATCCTT-3′ and 5′-AGCAAAAGAG 
GAGGCAACAA-3′, Ngf: 5′-GCAGTGAGGTGCATA 
GCGTA-3′ and 5′-CACTGAGAACTCCCCCATGT-3′, 
Nos2: 5′-GTGGTGACAAGCACATTTGG-3′ and 5′-GG 
CTGGACTTTTCACTCTGC-3′). The DNA fragments 
were separated in 1.5 % (w/v) agarose gels containing eth-
idium bromide. DNA bands were detected with a Vilber 
Lourmat. Signals were quantified by densitometry using 
ImageJ software.
Western immunoblot analysis
Cells were lysed for 30 min on ice in lysis buffer (1 % Tri-
ton X-100, 50 mM Tris–HCl (pH 7.6), 150 mM sodium 
chloride, 10  mM sodium pyrophosphate, 2  mM EDTA 
and Cømplete protease inhibitor cocktail from Roche 
Diagnostics). Cell debris was removed by centrifugation 
(15  min at 14,000×g and 4  °C) and protein concentra-
tions of lysates were determined using a bicinchoninic 
acid protein assay kit (Pierce). Samples were diluted in 
Laemmli buffer, boiled at 95 °C for 5 min, and centrifuged 
for 20 s at 16,100×g before loading. A total of 10–25 µg 
proteins were then subjected to denaturing 10 or 15  % 
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polyacrylamide gel electrophoresis and transferred onto 
Immobilon-P polyvinylidene difluoride membranes 
(EMD Millipore). Membranes were pre-incubated for 1 h 
at 20  °C in 5  % skim milk in TBS-T [50  mM Tris–HCl 
(pH 7.4), 150  mM NaCl and 0.1  % Tween-20]. Primary 
antibodies diluted in Western Blocking Reagent (Roche 
Diagnostics) were incubated over night at 4  °C. Then 
membranes were washed 3–5 times in TBS-T. Horse-
radish peroxidase-conjugated secondary antibodies in 
TBS-T supplemented with 5  % milk were incubated for 
1  h at 20  °C and membranes washed again 3–5 times 
with TBS-T. Detection of proteins was performed with 
the Immobilon Western Chemiluminescent HRP Sub-
strate (EMD Millipore) on Amersham Hyperfilm™ for 
enhanced chemiluminescence (GE Healthcare).
NF‑κB nuclear translocation
Primary astrocytes were cultured on poly-d-lysine 
and collagen coated coverslips. Cells were treated with 
0.007–3.5 µM recombinant αSYN or 0.1–1.0 µg/ml LPS 
in growth media for 6 h. After which the cells were fixed 
in 4  % (w/v) paraformaldehyde in PBS and permeabi-
lized with 1 % (v/v) Triton X-100 for 5 min and blocked 
in 10  % (v/v) normal goat serum in PBS solution for 
60  min at room temperature. Anti-p65 NF-κB (1:100) 
and anti-mouse-Alexa488 (1:1000) were diluted in 1  % 
(w/v) BSA in PBS and incubated for 1  h at room tem-
perature or over night at 4  °C in a humidified chamber. 
Nuclei were counterstained with 2 µg/ml Hoechst 33342 
in PBS for 10 min at room temperature. Coverslips were 
mounted in Mowiol/DABCO solution onto glass slides. 
Images were acquired with 25× objective with AxioIm-
ager microscope equipped with ApoTome Imaging sys-
tem and processed with AxioVision software. A blinded 
observer manually counted the number of nuclei posi-
tive for NF-κB as well as total nuclei in 200–400 cells per 
condition.
Uptake of exogenous αSYN
Primary astrocytes were plated in six-well cell culture 
plates. The cells were incubated with 0.007–3.5 µM recom-
binant synuclein, which was added to the growth media. 
The cells were treated for 1–48 h. In some experiments a 
1 h treatment was followed by a recovery time of 0.5–48 h, 
where the medium was replaced with fresh medium. The 
cells were washed twice in cold PBS, lysed and processed 
for Western immunoblot analysis as described above.
Statistical analyses
Each experiment was performed independently at least 
three times unless stated otherwise. The statistical anal-
yses were done with JMP 9 or StatView software (both 
from SAS Institute Inc). Comparisons were analyzed 
with either unpaired Student’s t test (when comparing 
differences between genotypes) or two-way ANOVA fol-
lowed by Fisher’s unprotected least significant difference 
(PLSD) post hoc test (when assessing inductions after 
treatments), as stated in the figure legends. P values less 
than 0.05 were considered as statistically significant.
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Additional files
Additional file 1: Figure S1. NO production in αSYN and TLR4-inhibitor 
treated astrocytes. Primary astrocytes were treated in OptiMEM (supple-
mented with penicillin G and streptomycin) with 5 µM of control peptide 
(ctrl pep; CP7: RNTISGNIYSARRRRRRRRR) or TLR4 inhibitor peptide (viper: 
KYSFKLILAEYRRRRRRRRR) (both from Imgenex/Biomol) two hours prior to 
the addition of recombinant αSYN (0.7 µM or 3.5 µM, as indicated) or LPS 
(0.1 µg/ml) as positive control or left untreated (Ø). 48 h later NO released 
to the media was measured using Griess reagent (Fluka/Sigma-Aldrich). 
The amount of NO was normalized to total protein amount in the sample 
well. The samples were incubated protected from light for 15 min, after 
which the optic absorption at 550 nm was measured (Model 680 Micro-
plate Reader, Bio-Rad). A standard curve made from 0 to 50 µM sodium 
nitrite was used as reference. Measurements were normalized against the 
total protein content of the well. Error bars are standard deviation; n = 16.
Additional file 2: Figure S2. Extracellular αSYN induces less p38 MAPK 
and JNK phosphorylation in Tlr4−/− than in Tlr4+/+ astrocytes. Primary 
astrocyte-rich cultures from littermate Tlr4−/− and Tlr4+/+ mice were left 
untreated (-) or treated with LPS (as positive control) and recombinant 
human αSYN for one hour, after which medium was replaced and cells let 
to recover for indicated times (A), or continuously for indicated times (B). 
Immediately after lysis the cell lysates were immunoblotted for phospho-
rylated p38 MAPK and JNK. Total p38 MAPK, total JNK and GAPDH serve 
as controls for equal protein loading. Arrows indicate the heights of JNK2 
α2 and β2 (48 kDa, black arrow), JNK1, JNK2α1 and JNK2β1 (44 kDa, grey 
arrow), and a potentially cross-reacting band possibly from phosphoryl-
ated ERK2 (41 kDa, open arrow). Several representative experiments 
shown for a total number of (A) N = 2 (Tlr4+/+) and N = 9 (Tlr4−/−) and 
(B) N = 4 (Tlr4+/+) AND N = 5 (Tlr4−/−) mice, respectively.
Additional file 3: Figure S3. Low levels of contaminating endotoxins 
and proteins in the recombinant synuclein preparations. (A) Endotoxin 
levels in the purified protein samples were measured with the 0.06 EU/
ml cut off using three dilutions of the samples (1:1, 1:10 and 1:25). Protein 
concentration was measured with nanodrop using the extinction factors 
ε(280, 0.1 %) 0.354 for αSYN and 0.417 for βSYN. The table indicates the con-
centrations of synuclein and endotoxin levels in the protein stocks used 
in this work. (B) Samples of purified recombinant αSYN and βSYN were 
tested for purity by a sensitive variant of Coomassie stained polyacryla-
mide gels. (C) Samples of purified synuclein proteins were immunoblot-
ted using antibodies specific for αSYN and βSYN, respectively. (D) Samples 
that were cut out from Coomassie stained polyacrylamide gels (indicated 
by red dashed boxes in the upper right panel) were trypsinized and the 
peptides were analyzed by mass spectroscopy.
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